vimarsana.com

Page 10 - Data Capture Solutions News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Bayer s IT hiring activity rises by 11 9% in February 2022

Bayer’s IT hiring rises 11.9% in February 2022 when compared with the previous month, according to GlobalData’s Job Analytics

United statesElectronic data capture solutions for clinical trialsNetwork administratorsContract research organisation for clinical trialsWeb developersJob analyticsMiscellaneous computer occupationsCentral americaEntry levelData capture solutionsResearch organisationCellular immune

Asia-Pacific s pharma industry IT hiring activity rises 1 1% in February 2022

Asia-Pacific witnessed a 1.1% rises in IT hiring activity in the pharma industry in February 2022, according to GlobalData’s Job Analytics index

Eli lillyParexel internationalElectronic data capture solutions for clinical trialsNetwork administratorsContract research organisation for clinical trialsWeb developersMinistry of healthNovo nordiskJob analyticsTesters occupationsComputer occupationsInformation analystsNew south walesEntry levelData capture solutionsResearch organisation

South & Central America s pharma industry IT hiring activity rises 18 1% in February 2022

South & Central America witnessed a 18.1% rises in IT hiring activity in the pharma industry in February 2022, according to GlobalData’s Job Analytics index

United statesCosta ricaSyneos healthElectronic data capture solutions for clinical trialsContract research organisation for clinical trialsWeb developersCentral americaJob analyticsTesters occupationsInformation analystsMiscellaneous computer occupationsSupport specialistsMid levelData capture solutionsResearch organisationCellular immune

Mount Sinai starts Phase I trial of egg-based Covid-19 vaccine

The Icahn School of Medicine at Mount Sinai has commenced a Phase I trial of an egg-based Covid-19 vaccine in healthy adult subjects.

Republic ofSean liuElectronic data capture solutions for clinical trialsIcahn school of medicine at mount sinaiContract research organisation for clinical trialsIcahn school of medicineIcahn schoolMount sinaiSinai infectious diseasesHospital medicineResearch organisationData capture solutionsEvent conception

Aldeyra commences Phase II trial of retinitis pigmentosa therapy

Aldeyra Therapeutics has commenced a Phase II trial of its ADX-2191 (intravitreal methotrexate 0.8%), to treat retinitis pigmentosa (RP).

North carolinaUnited statesDuke university medical centerTodd bradyElectronic data capture solutions for clinical trialsDrug administrationEu open market solutions for clinical trialsAldeyra therapeuticsMarket solutionsRegulatory consultationData capture solutions

vimarsana © 2020. All Rights Reserved.